Yüklüyor......
An in vivo half-life extended prolactin receptor antagonist can prevent STAT5 phosphorylation
Increasing evidence suggests that signaling through the prolactin/prolactin receptor axis is important for stimulation the growth of many cancers including glioblastoma multiforme, breast and ovarian carcinoma. Efficient inhibitors of signaling have previously been developed but their applicability...
Kaydedildi:
| Yayımlandı: | PLoS One |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Public Library of Science
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6504076/ https://ncbi.nlm.nih.gov/pubmed/31063493 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0215831 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|